Deanna Petersen biography
Deanna M. Petersen serves as Independent Director of the Company. Ms. Petersen has been Chief Business Officer at AvroBio since January of 2016. She was Vice President of Business Development for Shire Human Genetic Therapies from 2009 until 2015, where she initiated and managed partnering, licensing and merger and acquisition activities worldwide. From 2002 to 2009, Ms. Petersen was Vice President of Business Development for Agenus Inc., and from 1998 to 2002 she was Vice President and Executive Director of Business Development at Coley Pharmaceutical Group, Inc. Ms. Petersen was on the board of ADGE until completion of the ADGE Merger. Ms. Petersen is on the board of directors for the Massachusetts Biotechnology Association and was previously the Treasurer of the board of directors for the Healthcare Business Women’s Association, Boston Chapter. Ms. Petersen holds a B.S. in Biology from Iowa State University and a M.B.A. from the University of Iowa. Ms. Petersen is currently serving as a director of Tecogen, and is the Chair of Tecogen's Audit Committee and Nominating and Corporate Governance Committee.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
How old is Deanna Petersen?
Deanna Petersen is 58, she's been the Independent Director of Tecogen Inc since 2017. There are 8 older and 5 younger executives at Tecogen Inc. The oldest executive at Tecogen Inc is John Hatsopoulos, 86, who is the Lead Director.
What's Deanna Petersen's mailing address?
Deanna's mailing address filed with the SEC is C/O AVROBIO, INC., 100 TECHNOLOGY SQUARE, 6TH FLOOR, CAMBRIDGE, MA, 02139.
Insiders trading at Tecogen Inc
Over the last 10 years, insiders at Tecogen Inc have traded over $0 worth of Tecogen Inc stock and bought 1,217,820 units worth $1,140,029 . The most active insiders traders include Earl R Lewis, John Hatsopoulos, eCharlest Maxwell. On average, Tecogen Inc executives and independent directors trade stock every 38 days with the average trade being worth of $11,144. The most recent stock trade was executed by John Hatsopoulos on 19 August 2024, trading 10,000 units of TGEN stock currently worth $9,000.
What does Tecogen Inc do?
tecogen is a leading manufacturer of combined heat and power products including natural gas engine-driven cogeneration, air conditioning systems and high efficiency water heaters for industrial and commercial use. tecogen systems supply electric power, cooling or hot water while thermal energy from the engine is recovered and recycled resulting in reductions in both energy costs and greenhouse gas emissions. tecogen has an installed base of more than 2,000 units supported by an established network of engineering, sales and service personnel across the united states.
What does Tecogen Inc's logo look like?
Tecogen Inc executives and stock owners
Tecogen Inc executives and other stock owners filed with the SEC include:
-
John Whiting,
General Counsel, Secretary -
Benjamin M. Locke,
CEO & Director -
Benjamin Locke,
Chief Executive Officer, Principal Financial Officer, Treasurer, Director -
Robert Panora,
President, Chief Operating Officer -
Robert A. Panora,
Pres & COO -
John Kimball Whiting IV, J.D.,
Gen. Counsel & Sec. -
John Hatsopoulos,
Lead Director -
Earl Lewis,
Independent Director -
Laurence De Armada Garcia Roosevelt,
Independent Director -
Deanna Petersen,
Independent Director -
Ahmed Ghoniem,
Independent Director -
Angelina Galiteva,
Independent Chairperson of the Board -
Tristen Howell,
Office Mang. -
Dr. Abinand Rangesh Ph.D.,
CFO & Director -
Barbara Ann Bernard,
Managing Director of Communications -
Joseph B. Gehret Jr.,
Chief Technology Officer -
Roger P. Deschenes,
Chief Accounting Officer & Treasurer -
Bonnie Jean Brown,
Chief Accounting Officer -
Charlest Maxwell,
Director -
David A Garrison,
CFO, Treasurer and Secretary -
George N Hatsopoulos,
10% owner -
Ralph Jenkins,
Director -
Fred Holubow,
Director -
Abinand Rangesh,
Chief Executive Officer -
John M Albertine,
Director -
Susan B Hirsch,
Director